148. The Evolution Of The Neurohormonal Hypothesis With Dr. Milton Packer: Part 3 – Neutral Trials, A 2nd Chance, & A Paradigm Shift

By CardioNerds - Last Updated: April 17, 2025

CardioNerds (Amit Goyal, Daniel Ambinder) and Dr. Mark Belkin, (CardioNerds Correspondent) and Dr. Shirlene Obuobi (CardioNerds Ambassador) from University of Chicago are honored to bring to you the Dr. Milton Packer perspective on the evolution of the neurohormonal hypothesis as part of The CardioNerds Heart Success Series. In part 3, Dr. Packer reflects on the value of neutral trials and recounts the journey that led to the PARADIGM Trial.

Check out the CardioNerds Heart Failure Success Series Page for more heart success episodes and content!

This CardioNerds Heart Failure Success Series was created in memory of Dr. David Taylor. We thank our partners at the Heart Failure Society of America which is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation, and advocacy.

Originally published in cardionerds.com

Post Tags:Cardio Care Today
Advertisement
Advertisement